Radiation Research · 1989 · 248 citations · 62 references
Natural SciencesOncologyPharmacologyBiomedical OpticsBiophotonicsCancer PharmacologyLight-tissue InteractionPhotochemical KineticsPhotochemical SynthesisPhotochemistryPhotodynamic TherapyCancer Photodynamic TherapyIn Vivo StudiesPhotophysical MechanismsPhotosensitizersPhotosensitizing CompoundsSystemic AdministrationTumor SelectivityVisible Light Effects
Photodynamic therapy (PDT) is the treatment of malignant lesions with visible light following the systemic administration of a tumor-localizing photosensitizer. Pharmacological and photochemical properties of the photosensitizer are combined with precise delivery of laser-generated light to produce a treatment which can offer selective tumoricidal action. Hematoporphyrin derivative (HD) and a purified component called Photofrin II are currently being used in clinical PDT. Initial patient results have been encouraging, and considerable interest has developed in the synthesis and evaluation of new photosensitizers with improved photochemical and pharmacological characteristics. In addition, there has been a gradual increase in knowledge related to in vitro and in vivo mechanisms of action of PDT. This report provides an overview of the properties and applications of PDT. Information and data related to drug development, photochemistry, subcellular targets, in vivo responses, and clinical trials of PDT are presented.
62
Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal Photochemotherapy
Richard L. Edelson, Carole L. Berger, Francis P. Gasparro et al. · New England Journal of Medicine · 1987 · 1.2K citations
Medicine, Immunology, Oncology +10
Porphyrin localization and treatment of tumors
E. J. Land · British Journal of Cancer · 1985 · 636 citations · Full text
Medicine, Oncology, Pharmacology +11
Richard L. Lipson, Edward J. Baldes, Arthur M. Olsen · JNCI Journal of the National Cancer Institute · 1961 · 629 citations
Medicine, Hematology, Oncology +9